OLYMPUS CORP/S (OTCMKTS:OCPNY) Sets New 52-Week High at $13.34

OLYMPUS CORP/S (OTCMKTS:OCPNY)’s stock price reached a new 52-week high on Friday . The company traded as high as $13.34 and last traded at $13.34, with a volume of 1485 shares trading hands. The stock had previously closed at $12.97.

Separately, Zacks Investment Research upgraded shares of OLYMPUS CORP/S from a “sell” rating to a “hold” rating and set a $14.00 price objective for the company in a research note on Tuesday, August 13th.

The business’s 50 day moving average price is $12.02 and its 200 day moving average price is $17.36. The stock has a market capitalization of $18.27 billion, a P/E ratio of 266.75, a price-to-earnings-growth ratio of 2.85 and a beta of 0.60. The company has a debt-to-equity ratio of 0.28, a current ratio of 1.55 and a quick ratio of 0.98.

OLYMPUS CORP/S (OTCMKTS:OCPNY) last announced its quarterly earnings results on Friday, August 2nd. The company reported $0.06 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.01). OLYMPUS CORP/S had a return on equity of 3.50% and a net margin of 1.91%. The company had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.70 billion. As a group, analysts forecast that OLYMPUS CORP/S will post 0.46 earnings per share for the current fiscal year.


Olympus Corporation manufactures and sells precision machineries and instruments worldwide. The company operates through four segments: Medical Business, Scientific Solutions Business, Imaging Business, and Others. It offers endoscopic video endoscopy systems, endoscopic ultrasound systems, ultrasound endoscopes and probes, endoscopic ultrasound observation devices, capsule endoscopy systems, integrated documentation systems, therapeutic equipment, and ancillary products; cleaning, disinfecting, and sterilization systems; gastrointestinal, colono, duodeno, and broncho endoscopes; endoscopy products for gastroenterological surgery, bronchial surgery, urology, gynecology, orthopedic surgery, neurosurgery, and anesthesiology, as well as ear, nose, and throat; and therapeutic and surgical equipment, endoscope ancillary equipment, and endotherapy devices.

Further Reading: Return on Investment (ROI)

Receive News & Ratings for OLYMPUS CORP/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OLYMPUS CORP/S and related companies with MarketBeat.com's FREE daily email newsletter.